Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease
Adam Steensberg, the chief executive of Danish biotech Zealand Pharma, which is developing an alternative weight loss product based on a different hormone, says “there is a duopoly already” in the GLP-1 market. Combining different drugs could be a way of expanding the effects of GLP-1s further still. Doctors such as Perkovic envisage a possible […]
December 12, 2024 | Features, GLP-1, Health, Ozempic, Science, syndication, wegovy, weight loss, weight loss drugs | No comments